Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Apr 23, 2019 7:58am
98 Views
Post# 29657998

RE:RE:SHORTS COVERED

RE:RE:SHORTS COVERED

tomchoco wrote: What do you think an announcement of Phase 2 will do to the stock price? Other than the fact that we trade on a terrible exchange where the price can be manipulated easily and some sort of funding will be needed(money at present is small), I would still be hard pressed to play this stock from the short side. Investors have seen what a big announcement can do to a biotech and shorts can be blown out of the water.I was an option trader for many years on a regional stock exchange and traded biotechs and pharms.. Always protected myself by using call options to hedge my short bet if I decided to take a short position. Hopefully one day TLT will be located on a major exchange and investors can employ thise strategies for maximum profit potential.


TLT seems to have money.. 3 to 4.5M from what we can see. They'd have to issue another short form prospectus to finance no? 

From my experience, commencement of PH2 would normally be a typical venture sell on news situation for us,,,,, small action, look good, then the venture vermin would turn over shares for their 20% and kill the momentum. There isn't enough capital infused on the venture,, for many good reasons, to overcome these traders. There is one exception now which is there will be a full pump from frustys crew to take it as high as possible so they can execute the .54 warrants and make money. Your average joe isn't shorting this company so maybe it's their clan... shorts are all covered now,, maybe now they let it run. 

Who knows what other announcements are lined up and what potency they will have. This year could finally be different. I think we're at a spot where a new level over a dollar has to be coming regardless of manipulations.

Bullboard Posts